EXPERIENCE OF USING THE DRUG SELEXIPAG IN THE TREATMENT OF PATIENTS WITH PULMONARY ARTERIAL HYPERTENSION

被引:1
|
作者
Karelkina, E. V. [1 ]
Goncharova, N. S. [1 ]
Simakova, M. A. [1 ]
Moiseeva, O. M. [1 ]
机构
[1] FGBU Natl Med Res Ctr, St Petersburg, Russia
关键词
PROSTACYCLIN-RECEPTOR AGONIST;
D O I
10.18087/cardio.2020.4.n1026
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
[No abstract available]
引用
收藏
页码:36 / 42
页数:6
相关论文
共 42 条
  • [1] Selexipag for the treatment of pulmonary arterial hypertension
    Skoro-Sajer, Nika
    Lang, Irene Marthe
    EXPERT OPINION ON PHARMACOTHERAPY, 2014, 15 (03) : 429 - 436
  • [2] Pharmacokinetic drug evaluation of selexipag for the treatment of pulmonary arterial hypertension
    Sardana, Mayank
    Moll, Matthew
    Farber, Harrison W.
    EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 2016, 12 (12) : 1513 - 1520
  • [3] Selexipag for the Treatment of Pulmonary Arterial Hypertension
    Sitbon, Olivier
    Channick, Richard
    Chin, Kelly M.
    Frey, Aline
    Gaine, Sean
    Galie, Nazzareno
    Ghofrani, Hossein-Ardeschir
    Hoeper, Marius M.
    Lang, Irene M.
    Preiss, Ralph
    Rubin, Lewis J.
    Di Scala, Lilla
    Tapson, Victor
    Adzerikho, Igor
    Liu, Jinming
    Moiseeva, Olga
    Zeng, Xiaofeng
    Simonneau, Gerald
    McLaughlin, Vallerie V.
    NEW ENGLAND JOURNAL OF MEDICINE, 2015, 373 (26) : 2522 - 2533
  • [4] Selexipag for the treatment of pulmonary arterial hypertension
    Noel, Zachary R.
    Kido, Kazuhiko
    Macaulay, Tracy E.
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2017, 74 (15) : 1135 - 1141
  • [5] Selexipag for the treatment of pulmonary arterial hypertension
    Sharma, Kamal
    EXPERT REVIEW OF RESPIRATORY MEDICINE, 2016, 10 (01) : 1 - 3
  • [6] Selexipag for the treatment of pulmonary arterial hypertension
    Richter, Manuel Jonas
    Gall, Henning
    Grimminger, Jan
    Grimminger, Friedrich
    Ghofrani, Hossein-Ardeschir
    EXPERT OPINION ON PHARMACOTHERAPY, 2016, 17 (13) : 1825 - 1834
  • [7] A Special Focus on Selexipag - Treatment of Pulmonary Arterial Hypertension
    Sorensen, Louise M.
    Wehland, Markus
    Krueger, Marcus
    Simonsen, Ulf
    Nassef, Mohamed Z.
    Infanger, Manfred
    Grimm, Daniela
    CURRENT PHARMACEUTICAL DESIGN, 2017, 23 (34) : 5191 - 5199
  • [8] Selexipag: A New Treatment Agent for Pulmonary Arterial Hypertension
    Yazici, Onur
    Gungor, Hasan
    MEANDROS MEDICAL AND DENTAL JOURNAL, 2019, 20 (01): : 1 - 6
  • [9] Selexipag: A Review in Pulmonary Arterial Hypertension
    Duggan, Sean T.
    Keam, Susan J.
    Burness, Celeste B.
    AMERICAN JOURNAL OF CARDIOVASCULAR DRUGS, 2017, 17 (01) : 73 - 80
  • [10] Selexipag in the treatment of pulmonary arterial hypertension: design, development, and therapy
    Hardin, Elizabeth Ashley
    Chin, Kelly M.
    DRUG DESIGN DEVELOPMENT AND THERAPY, 2016, 10 : 3747 - 3754